Close Menu

NEW YORK, Feb 27 - Packard BioScience said Tuesday it completed the sale of its nuclear products division, Canberra Industries, to Cogema of France.

Cogema bought Canberra for $170 million. Packard of Meriden, Conn.,  has said it would use the proceeds of the sale for debt repayment, research and development, and general purposes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.